EP2802366A1 - Systems and methods for delivering fluid to a wound therapy dressing - Google Patents

Systems and methods for delivering fluid to a wound therapy dressing

Info

Publication number
EP2802366A1
EP2802366A1 EP13702512.8A EP13702512A EP2802366A1 EP 2802366 A1 EP2802366 A1 EP 2802366A1 EP 13702512 A EP13702512 A EP 13702512A EP 2802366 A1 EP2802366 A1 EP 2802366A1
Authority
EP
European Patent Office
Prior art keywords
fluid
positive pressure
pressure
valve
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP13702512.8A
Other languages
German (de)
French (fr)
Other versions
EP2802366B1 (en
Inventor
Larry Tab Randolph
Richard Marvin Kazala
Kevin Bendele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KCI Licensing Inc
Original Assignee
KCI Licensing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47633545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2802366(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by KCI Licensing Inc filed Critical KCI Licensing Inc
Priority to EP15179060.7A priority Critical patent/EP2965768B1/en
Priority to EP17202174.3A priority patent/EP3308809B1/en
Publication of EP2802366A1 publication Critical patent/EP2802366A1/en
Application granted granted Critical
Publication of EP2802366B1 publication Critical patent/EP2802366B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/92Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
    • A61F13/05
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71Suction drainage systems
    • A61M1/77Suction-irrigation systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/80Suction pumps
    • A61M1/802Suction pumps by vacuum created above a liquid flowing from a closed container
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/84Drainage tubes; Aspiration tips
    • A61M1/85Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71Suction drainage systems
    • A61M1/74Suction control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/0007Special media to be introduced, removed or treated introduced into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/04Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body

Definitions

  • the subject matter of this specification relates generally to healing of wounds and wound-treatment therapies. More particularly, but not by way of limitation, the subject matter relates to systems and methods for improving fluid-instillation and negative pressure wound therapy (NPWT) apparatuses and methods.
  • NGWT negative pressure wound therapy
  • Typical instillation therapy instills fluid into a wound under a low positive pressure.
  • the instilled fluid should reach all exposed tissue surfaces.
  • the practice of fully filling a wound with instillation fluid, combined with the application of porous wound fillers and negative pressure to help distribute fluid, can provide effective instillation therapy.
  • Such techniques can have numerous disadvantages. For example, filling a wound with fluid is wasteful, particularly where expensive fluids (e.g. antibiotics) are used as the bulk of the fluid enters the dressing (e.g., a foam) to enable the surface of the wound to be coated with instillation fluid.
  • instilled fluid Even where the instilled fluid is inexpensive, large volumes of fluid may be involved, requiring frequent canister changes that may lead to user dissatisfaction. Although low positive pressures are typically used to fill the wound cavity, the hydraulic (essentially incompressible) nature of the fluid means that over filling can quickly cause drape leakage. Tortuous contours within a wound cavity may be difficult to reach with both foam dressings and liquid-fill techniques as gas pockets may be created. Applying a low vacuum during liquid instillation (to help maintain a seal and reduce leaking, to minimize patient discomfort, and to aid fluid distribution) can be problematic as instilled fluid may be removed before it is fully distributed through the dressing.
  • a system for delivering fluid to a negative pressure wound therapy dressing includes: an actuator configured to engage a fluid reservoir; and a pressure source configured to provide positive pressure to the actuator and negative pressure to a wound dressing.
  • the actuator can be, for example, configured as a compression sleeve and/or a bladder.
  • Some embodiments may additionally include: a fluid reservoir; a wound dressing; and a fluid control device in fluid communication with the fluid reservoir and the wound dressing.
  • the fluid control device can be a control valve, such as, for example, a solenoid-actuated pinch valve and/or an orifice. Certain embodiments may also include a control system configured to control the fluid control device.
  • the pressure source may include a vacuum diaphragm pump.
  • Specific embodiments may also include a valve in fluid communication with the actuator and the pressure source, where the valve can be configured to vent to atmosphere.
  • the pressure source can be, for example, configured to provide a pressure of between approximately 0.1 psig and approximately 1.0 psig.
  • a system for delivering fluid to a negative pressure wound therapy dressing where the system includes: a pump comprising a vacuum port and a positive pressure port; an expandable member in fluid communication with the positive pressure port, wherein the expandable member is configured to engage a fluid reservoir and expel fluid from the fluid reservoir; and a valve in fluid communication with the positive pressure port and the expandable member, wherein the valve is configured to vent pressure to atmosphere.
  • Specific embodiments may additionally include a wound dressing in fluid communication with the vacuum port. Further, specific embodiments may additionally include a control system configured to control a fluid flow from the fluid reservoir.
  • the control system can be configured to control a control valve.
  • the control valve can be, for example, a solenoid-actuated pinch valve.
  • the positive pressure port can be configured to provide a pressure of between approximately 0.1 psig and approximately 1.0 psig to the expandable member.
  • a method of delivering fluid to a negative pressure wound therapy dressing includes: operating a pressure source to exert a positive pressure on a fluid reservoir and a negative pressure on a wound dressing of a negative pressure wound therapy system; monitoring the positive pressure and opening a valve to allow fluid to flow from the fluid reservoir to the wound dressing; closing the valve to restrict fluid flow from the fluid reservoir to the wound dressing; and maintaining negative pressure from the pressure source to the wound dressing.
  • the pressure source may be a diaphragm vacuum pump.
  • the positive pressure may be between approximately 0.1 psig and approximately 1.0 psig.
  • a system for delivering fluid to a wound therapy dressing includes an actuator, a pressure source, and a fluid control device.
  • the actuator is configured to engage a fluid reservoir. Further, the actuator is adapted to expel the fluid from the fluid reservoir.
  • the fluid reservoir is adapted to be in fluid communication with the wound therapy dressing.
  • the pressure source is configured to provide positive pressure to the actuator and negative pressure to the wound therapy dressing.
  • the fluid control device is adapted to be in fluid communication between the fluid reservoir and the wound dressing, wherein fluid communication between the fluid reservoir and the wound dressing is provided through the fluid control device.
  • a system for delivering fluid to a wound therapy dressing includes a pump, an expandable member, and a valve.
  • the pump comprises a vacuum port and a positive pressure port, the vacuum port being adapted to be in fluid communication with the wound therapy dressing.
  • the expandable member is in fluid communication with the positive pressure port. Further, the expandable member is configured to exert a force on fluid within a fluid reservoir to expel fluid from the fluid reservoir, the fluid reservoir being adapted to be in fluid communication with the wound therapy dressing.
  • the valve is in fluid communication between the positive pressure port and the expandable member, wherein positive pressure from the positive pressure port is provided to the expandable member through the valve, and wherein the valve is configured to vent excess pressure to atmosphere.
  • a method of delivering fluid to a wound therapy dressing includes the step of operating a pressure source adapted to exert a positive pressure on fluid in a fluid reservoir and a negative pressure on the wound therapy dressing. Further, the method includes monitoring the positive pressure on the fluid. Additionally, the method includes providing a fluid control device adapted to supply the fluid from the fluid reservoir to the wound therapy dressing, the fluid control device comprising a control valve and a metering orifice, the metering orifice being sized to provide a fluid flow rate according to the positive pressure on the fluid.
  • the method includes opening the control valve to provide a predetermined volume of the fluid from the fluid reservoir to the wound therapy dressing, the predetermined volume of the fluid corresponding to the fluid flow rate from the fluid reservoir for an elapsed time period. Even further, the method may include the steps of closing the control valve to restrict the fluid flow from the fluid reservoir to the wound therapy dressing after the elapsed time period, and maintaining negative pressure from the pressure source to the wound dressing.
  • Coupled is defined as connected, although not necessarily directly, and not necessarily mechanically.
  • substantially and its variations are defined as being largely but not necessarily wholly what is specified as understood by one of ordinary skill in the art, and in one non-limiting embodiment "substantially” refers to ranges within 10%, preferably within 5%, more preferably within 1%, and most preferably within 0.5% of what is specified.
  • a step of a method or an element of a device that "comprises,” “has,” “includes” or “contains” one or more features possesses those one or more features, but is not limited to possessing only those one or more features.
  • a device or structure that is configured in a certain way is configured in at least that way, but may also be configured in ways that are not listed.
  • negative pressure refers to an absolute pressure that is lower than the absolute atmospheric pressure at the location of use of the device.
  • a stated level of negative pressure in a region is therefore a relative measure between the absolute atmospheric pressure and the absolute pressure in the region.
  • a statement that the negative pressure is decreasing means the pressure in the region is moving towards atmospheric pressure (i.e. the absolute pressure is increasing).
  • numeric values are used a negative sign is placed in front of the numeric pressure value to indicate the value is a negative pressure relative to atmospheric pressure.
  • FIG. 1 is a schematic diagram illustrating one embodiment of a system for delivering fluid to a wound therapy dressing.
  • FIG. 2 is a schematic diagram illustrating another embodiment of a system for delivering fluid to a wound therapy dressing.
  • FIG. 3 is schematic flowchart diagram illustrating one embodiment of a method for delivering fluid to a wound therapy dressing.
  • FIG. 1 illustrates one exemplary embodiment of a system 100 for delivering fluid to a negative pressure wound therapy dressing.
  • system 100 includes a reservoir 110, a wound dressing 120, and a pressure source 130.
  • pressure source 130 may be a vacuum pump, including, for example, a diaphragm vacuum pump.
  • reservoir 110 may be configured as a polyethylene bag similar to those used for intravenous fluid delivery.
  • pressure source 130 provides a negative pressure to reservoir 110 and wound dressing 120, and a positive pressure to an actuator 115 configured to force fluid from reservoir 110.
  • Reservoir 110 may contain saline, antibiotic fluid, or any other fluid suitable for use in instillation therapy.
  • actuator 115 is an expandable member, such as a compression sleeve, that is configured to compress reservoir 110 and expel fluid from reservoir 110.
  • FIG. 1 depicts actuator 115 as a compression sleeve positioned circumferentially about reservoir 110.
  • the compression sleeve may be adapted to expand at least in an inward direction toward reservoir 110 to engage and compress reservoir 110, i.e., the internal circumference of the compression sleeve may decrease as the compression sleeve expands.
  • system 100 additionally includes a fluid control device 150 in fluid communication with reservoir 110 and wound dressing 120.
  • fluid control device 150 may comprise one or more valves or orifices configured to control the flow of fluid from reservoir 110 to wound dressing 120.
  • pressure source 130 provides a negative pressure from a vacuum port 138 that is in fluid communication with wound dressing 120 via conduit 116 and with reservoir 110 via conduit 114 and 112.
  • Pressure source 130 is also configured to provide a positive pressure from a pressure port 132 to actuator 115 via conduits 134 and 136 during operation.
  • a valve 135 in fluid communication between pressure port 132 and actuator 115 ⁇ e.g. via conduits 134 and 136) can be used to vent positive pressure to atmosphere.
  • system 100 Prior to operation, system 100 is prepared so that actuator 115 is engaged with reservoir 110, containing fluid to be delivered to wound dressing 120.
  • Reservoir 110 is in fluid communication with fluid control device 150 via conduit 112 and with wound dressing 120 via conduit 114.
  • Wound dressing 120 is in turn in fluid communication with vacuum port 138 via conduit 116.
  • pressure port 132 is in fluid communication with actuator 115 via conduits 134 and 136, and valve 135.
  • Pressure source 130 is operated so that positive pressure is delivered to actuator 115.
  • the pressure provided to actuator 115 is less than 2.0 psig, and in specific embodiments, the pressure level is less than 1.0 psig. In even more specific embodiments, the pressure level is less than 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, O.3., 0.2 or 0.1 psig.
  • valve 135 The pressure level delivered to actuator 115 can be controlled by valve 135.
  • valve 135 may be a three-way valve configured to vent excess pressure to atmosphere. Actuator 115 can then exert a force on reservoir 110 so that fluid can be expelled from reservoir 1 10 via conduit 112.
  • Fluid control device 150 can be operated to control the amount (e.g. , the total volume, the flow rate, or another fluid flow parameter that is desired to be controlled) of fluid expelled from reservoir 110.
  • fluid control device 150 includes a control valve 151 and a metering flow orifice 152.
  • Valve 151 may be configured, for example, as a solenoid valve or pinch valve that can be used to stop the flow of fluid from reservoir 110.
  • valve 135 when valve 151 is closed to stop fluid flow, valve 135 can be positioned to vent the positive pressure developed by pressure source 130 to atmosphere.
  • fluid control device 150 may comprise a different combination of components, including for example, a control valve without an orifice or an orifice without a control valve.
  • fluid control device 150 may be controlled via an appropriate control system 155 (e.g., a system comprising software, pressure sensors or other appropriate components).
  • control system 155 may receive an input from a pressure sensor 153 configured to detect a pressure exerted on actuator 115. As shown in FIG. 1, pressure sensor 153 detects pressure in conduit 136, wherein conduit 136 is in fluid communication with actuator 115.
  • Control system 155 may also be configured to provide an output to valve 151 to control the flow of fluid from reservoir 110, based on, for example, the pressure exerted on actuator 115 and the force, or pressure, exerted by the actuator 115 on reservoir 110 and the fluid therein.
  • Fluid control device 150 can be operated so that a known, or predetermined, volume and/or flow rate of fluid is expelled from reservoir 110 based on the known pressure level exerted on reservoir 110 and the valve position and/or orifice size of control device 150.
  • the rate of fluid flow from reservoir 110 may be controlled at 100 ml/minute. In other embodiments, the flow rate may be controlled at 90, 80, 70, 60, 50, 40, 30, 20 or 10 ml/min.
  • metering flow orifice 152 can be sized to provide a particular flow rate at a known pressure provided to reservoir 110.
  • the flow rate can be maintained at a substantially constant level because actuator 115 can expand as the volume in reservoir 110 is reduced.
  • valve 151 can be operated for a specific length of time to provide a desired fluid volume to wound dressing 120, i.e., the predetermined or desired volume of fluid from reservoir 110 may correspond to the fluid flow rate from reservoir 110 for an elapsed time period. This can reduce the likelihood that excess fluid will be delivered to wound dressing 120 and cause leakage.
  • FIG. 1 is merely one exemplary embodiment.
  • Other exemplary embodiments may comprise a different configuration or arrangement of components.
  • FIG. 2 an exemplary embodiment of a system 200 is shown that is similar to that of FIG. 1, but includes an actuator 215 that is configured as an expandable bladder.
  • the components of system 200 sharing the same element numbering as the components discussed in connection with system 100 are equivalent, and thus, will not be further described herein.
  • actuator 215 expands as the pressure provided from pressure source 130 is increased.
  • actuator 215 is contained within a reservoir 210, such as a housing. As actuator 215 expands, actuator 215 displaces fluid in reservoir 210 to expel fluid from reservoir 210 in a similar manner as described above in connection with system 100 to provide controlled fluid flow from reservoir 210 to wound dressing 120.
  • FIG. 3 a flow chart is provided to illustrate an embodiment of a method that may be utilized to operate systems 100 and 200.
  • the flow chart is generally set forth as a logical flow chart diagram. As such, the depicted order and labeled steps are indicative of one non-limiting embodiment of the presented method. Other steps, methods, and the order of execution thereof may be conceived that fall within the scope of this specification.
  • a method 300 comprising a series of steps that may be executed for the operation of an exemplary system according to this disclosure.
  • Certain embodiments may comprise a tangible computer readable medium comprising computer readable code that, when executed by a computer, causes the computer to perform operations comprising the steps disclosed in FIG. 3.
  • step 310 comprises operating a pressure source to exert a positive pressure on a fluid reservoir and to exert a negative pressure on a wound dressing of a negative wound pressure therapy system.
  • Step 320 comprises monitoring a reservoir or fluid pressure and opening a valve to allow fluid to flow from the fluid reservoir to the wound dressing.
  • Step 330 comprises closing the valve to restrict fluid flow from the fluid reservoir to the wound dressing.
  • Step 340 comprises maintaining negative pressure from the pressure source to the wound dressing.
  • the method may additionally include the steps of providing the previously described fluid control device 150, opening control valve 151 associated with fluid control device 150, and subsequently closing control valve 151 after an elapsed time period sufficient to deliver a predetermined volume of fluid from reservoir 110, 210.

Abstract

Provided are systems (100) and methods for delivery of fluid to a wound therapy dressing. In exemplary embodiments, a pressure source (130) provides negative pressure to a wound dressing (120) and positive pressure to an actuator that expels fluid from a fluid reservoir.

Description

SYSTEMS AND METHODS FOR DELIVERING FLUID
TO A WOUND THERAPY DRESSING
BACKGROUND
1. Cross-Reference to Related Application
[0001] This application claims priority to U.S. Provisional Patent Application No. 61/585,055 filed January 10, 2012, entitled SYSTEMS AND METHODS FOR DELIVERING FLUID TO A WOUND THERAPY DRESSING, the disclosure of which is hereby incorporated by reference in its entirety.
2. Field
[0002] The subject matter of this specification relates generally to healing of wounds and wound-treatment therapies. More particularly, but not by way of limitation, the subject matter relates to systems and methods for improving fluid-instillation and negative pressure wound therapy (NPWT) apparatuses and methods.
3. Discussion
[0003] Clinical studies and practice have shown that providing a reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as "negative pressure wound therapy," "reduced pressure therapy," or "vacuum therapy") provides a number of benefits, including faster healing and increased formulation of granulation tissue. Typically, reduced pressure is applied to tissue through a porous pad or other manifold device. The porous pad contains cells or pores that are capable of distributing reduced pressure to the tissue and channeling fluids that are drawn from the tissue. The porous pad may be incorporated into a dressing having other components that facilitate treatment.
[0004] Typical instillation therapy instills fluid into a wound under a low positive pressure. For maximum therapeutic effect, the instilled fluid should reach all exposed tissue surfaces. The practice of fully filling a wound with instillation fluid, combined with the application of porous wound fillers and negative pressure to help distribute fluid, can provide effective instillation therapy. Such techniques can have numerous disadvantages. For example, filling a wound with fluid is wasteful, particularly where expensive fluids (e.g. antibiotics) are used as the bulk of the fluid enters the dressing (e.g., a foam) to enable the surface of the wound to be coated with instillation fluid.
[0005] Even where the instilled fluid is inexpensive, large volumes of fluid may be involved, requiring frequent canister changes that may lead to user dissatisfaction. Although low positive pressures are typically used to fill the wound cavity, the hydraulic (essentially incompressible) nature of the fluid means that over filling can quickly cause drape leakage. Tortuous contours within a wound cavity may be difficult to reach with both foam dressings and liquid-fill techniques as gas pockets may be created. Applying a low vacuum during liquid instillation (to help maintain a seal and reduce leaking, to minimize patient discomfort, and to aid fluid distribution) can be problematic as instilled fluid may be removed before it is fully distributed through the dressing.
[0006] The referenced shortcomings are not intended to be exhaustive, but rather are among many that tend to impair the effectiveness of previously known techniques in fluid delivery to wound dressings; however, those mentioned here are sufficient to demonstrate that the methodologies appearing in the art have not been satisfactory and that a significant need exists for the techniques described and claimed in this disclosure. For at least the reasons described above, improved wound treatment systems and methods are therefore desired.
SUMMARY
[0007] From the foregoing discussion, it should be apparent that a need exists for a system and method for improved delivery of fluid to a wound therapy dressing. The method in the disclosed embodiments substantially includes the steps necessary to carry out the operation of the described system.
[0008] In one embodiment, provided is a system for delivering fluid to a negative pressure wound therapy dressing, where the system includes: an actuator configured to engage a fluid reservoir; and a pressure source configured to provide positive pressure to the actuator and negative pressure to a wound dressing. The actuator can be, for example, configured as a compression sleeve and/or a bladder. Some embodiments may additionally include: a fluid reservoir; a wound dressing; and a fluid control device in fluid communication with the fluid reservoir and the wound dressing.
[0009] In specific embodiments, the fluid control device can be a control valve, such as, for example, a solenoid-actuated pinch valve and/or an orifice. Certain embodiments may also include a control system configured to control the fluid control device.
[0010] In specific embodiments, the pressure source may include a vacuum diaphragm pump. Specific embodiments may also include a valve in fluid communication with the actuator and the pressure source, where the valve can be configured to vent to atmosphere. The pressure source can be, for example, configured to provide a pressure of between approximately 0.1 psig and approximately 1.0 psig.
[0011] In another embodiment, provided is a system for delivering fluid to a negative pressure wound therapy dressing, where the system includes: a pump comprising a vacuum port and a positive pressure port; an expandable member in fluid communication with the positive pressure port, wherein the expandable member is configured to engage a fluid reservoir and expel fluid from the fluid reservoir; and a valve in fluid communication with the positive pressure port and the expandable member, wherein the valve is configured to vent pressure to atmosphere.
[0012] Specific embodiments may additionally include a wound dressing in fluid communication with the vacuum port. Further, specific embodiments may additionally include a control system configured to control a fluid flow from the fluid reservoir. For example, the control system can be configured to control a control valve. The control valve can be, for example, a solenoid-actuated pinch valve. In specific embodiments, the positive pressure port can be configured to provide a pressure of between approximately 0.1 psig and approximately 1.0 psig to the expandable member.
[0013] In yet another embodiment, provided is a method of delivering fluid to a negative pressure wound therapy dressing, where the method includes: operating a pressure source to exert a positive pressure on a fluid reservoir and a negative pressure on a wound dressing of a negative pressure wound therapy system; monitoring the positive pressure and opening a valve to allow fluid to flow from the fluid reservoir to the wound dressing; closing the valve to restrict fluid flow from the fluid reservoir to the wound dressing; and maintaining negative pressure from the pressure source to the wound dressing.
[0014] In specific embodiments, the pressure source may be a diaphragm vacuum pump. In particular embodiments, the positive pressure may be between approximately 0.1 psig and approximately 1.0 psig.
[0015] In yet another embodiment, provided is a system for delivering fluid to a wound therapy dressing. The system includes an actuator, a pressure source, and a fluid control device. The actuator is configured to engage a fluid reservoir. Further, the actuator is adapted to expel the fluid from the fluid reservoir. The fluid reservoir is adapted to be in fluid communication with the wound therapy dressing. The pressure source is configured to provide positive pressure to the actuator and negative pressure to the wound therapy dressing. The fluid control device is adapted to be in fluid communication between the fluid reservoir and the wound dressing, wherein fluid communication between the fluid reservoir and the wound dressing is provided through the fluid control device.
[0016] In yet another embodiment, provided is a system for delivering fluid to a wound therapy dressing. The system includes a pump, an expandable member, and a valve. The pump comprises a vacuum port and a positive pressure port, the vacuum port being adapted to be in fluid communication with the wound therapy dressing. The expandable member is in fluid communication with the positive pressure port. Further, the expandable member is configured to exert a force on fluid within a fluid reservoir to expel fluid from the fluid reservoir, the fluid reservoir being adapted to be in fluid communication with the wound therapy dressing. The valve is in fluid communication between the positive pressure port and the expandable member, wherein positive pressure from the positive pressure port is provided to the expandable member through the valve, and wherein the valve is configured to vent excess pressure to atmosphere.
[0017] In yet another embodiment, provided is a method of delivering fluid to a wound therapy dressing. The method includes the step of operating a pressure source adapted to exert a positive pressure on fluid in a fluid reservoir and a negative pressure on the wound therapy dressing. Further, the method includes monitoring the positive pressure on the fluid. Additionally, the method includes providing a fluid control device adapted to supply the fluid from the fluid reservoir to the wound therapy dressing, the fluid control device comprising a control valve and a metering orifice, the metering orifice being sized to provide a fluid flow rate according to the positive pressure on the fluid. Further, the method includes opening the control valve to provide a predetermined volume of the fluid from the fluid reservoir to the wound therapy dressing, the predetermined volume of the fluid corresponding to the fluid flow rate from the fluid reservoir for an elapsed time period. Even further, the method may include the steps of closing the control valve to restrict the fluid flow from the fluid reservoir to the wound therapy dressing after the elapsed time period, and maintaining negative pressure from the pressure source to the wound dressing.
[0018] Other features and associated advantages will become apparent with reference to the following detailed description of specific embodiments in connection with the accompanying drawings.
[0019] The term "coupled" is defined as connected, although not necessarily directly, and not necessarily mechanically.
[0020] The terms "a" and "an" are defined as one or more unless this disclosure explicitly requires otherwise.
[0021] The term "substantially" and its variations are defined as being largely but not necessarily wholly what is specified as understood by one of ordinary skill in the art, and in one non-limiting embodiment "substantially" refers to ranges within 10%, preferably within 5%, more preferably within 1%, and most preferably within 0.5% of what is specified.
[0022] The terms "comprise" (and any form of comprise, such as "comprises" and "comprising"), "have" (and any form of have, such as "has" and "having"), "include" (and any form of include, such as "includes" and "including") and "contain" (and any form of contain, such as "contains" and "containing") are open-ended linking verbs. As a result, a method or device that "comprises," "has," "includes" or "contains" one or more steps or elements possesses those one or more steps or elements, but is not limited to possessing only those one or more elements. Likewise, a step of a method or an element of a device that "comprises," "has," "includes" or "contains" one or more features possesses those one or more features, but is not limited to possessing only those one or more features. Furthermore, a device or structure that is configured in a certain way is configured in at least that way, but may also be configured in ways that are not listed.
[0023] The term "negative pressure" refers to an absolute pressure that is lower than the absolute atmospheric pressure at the location of use of the device. A stated level of negative pressure in a region is therefore a relative measure between the absolute atmospheric pressure and the absolute pressure in the region. A statement that the negative pressure is decreasing means the pressure in the region is moving towards atmospheric pressure (i.e. the absolute pressure is increasing). Where numeric values are used a negative sign is placed in front of the numeric pressure value to indicate the value is a negative pressure relative to atmospheric pressure.
BRIEF DESCRIPTION OF THE DRAWINGS
[0024] The following drawings form part of this specification and are included to further demonstrate certain aspects of exemplary embodiments of the subject matter described herein.
[0025] FIG. 1 is a schematic diagram illustrating one embodiment of a system for delivering fluid to a wound therapy dressing.
[0026] FIG. 2 is a schematic diagram illustrating another embodiment of a system for delivering fluid to a wound therapy dressing.
[0027] FIG. 3 is schematic flowchart diagram illustrating one embodiment of a method for delivering fluid to a wound therapy dressing.
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
[0028] Various features and advantageous details are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well known starting materials, processing techniques, components, and equipment are omitted so as not to unnecessarily obscure the invention in detail. It should be understood, however, that the detailed description and the specific examples, while indicating embodiments of the invention, are given by way of illustration only, and not by way of limitation. Various substitutions, modifications, additions, and/or rearrangements within the spirit and/or scope of the underlying inventive concept will become apparent to those skilled in the art from this disclosure.
[0029] FIG. 1 illustrates one exemplary embodiment of a system 100 for delivering fluid to a negative pressure wound therapy dressing. In the exemplary embodiment shown, system 100 includes a reservoir 110, a wound dressing 120, and a pressure source 130. In exemplary embodiments, pressure source 130 may be a vacuum pump, including, for example, a diaphragm vacuum pump. In exemplary embodiments, reservoir 110 may be configured as a polyethylene bag similar to those used for intravenous fluid delivery.
[0030] In the embodiment of FIG. 1, pressure source 130 provides a negative pressure to reservoir 110 and wound dressing 120, and a positive pressure to an actuator 115 configured to force fluid from reservoir 110. Reservoir 110 may contain saline, antibiotic fluid, or any other fluid suitable for use in instillation therapy. As shown in FIG. 1, actuator 115 is an expandable member, such as a compression sleeve, that is configured to compress reservoir 110 and expel fluid from reservoir 110. For example, FIG. 1 depicts actuator 115 as a compression sleeve positioned circumferentially about reservoir 110. The compression sleeve may be adapted to expand at least in an inward direction toward reservoir 110 to engage and compress reservoir 110, i.e., the internal circumference of the compression sleeve may decrease as the compression sleeve expands.
[0031] Continuing with FIG. 1, system 100 additionally includes a fluid control device 150 in fluid communication with reservoir 110 and wound dressing 120. As discussed in greater detail below, fluid control device 150 may comprise one or more valves or orifices configured to control the flow of fluid from reservoir 110 to wound dressing 120.
[0032] During operation of system 100, pressure source 130 provides a negative pressure from a vacuum port 138 that is in fluid communication with wound dressing 120 via conduit 116 and with reservoir 110 via conduit 114 and 112. Pressure source 130 is also configured to provide a positive pressure from a pressure port 132 to actuator 115 via conduits 134 and 136 during operation. A valve 135 in fluid communication between pressure port 132 and actuator 115 {e.g. via conduits 134 and 136) can be used to vent positive pressure to atmosphere. [0033] Prior to operation, system 100 is prepared so that actuator 115 is engaged with reservoir 110, containing fluid to be delivered to wound dressing 120. Reservoir 110 is in fluid communication with fluid control device 150 via conduit 112 and with wound dressing 120 via conduit 114. Wound dressing 120 is in turn in fluid communication with vacuum port 138 via conduit 116. Furthermore, pressure port 132 is in fluid communication with actuator 115 via conduits 134 and 136, and valve 135.
[0034] Pressure source 130 is operated so that positive pressure is delivered to actuator 115. In certain exemplary embodiments, the pressure provided to actuator 115 is less than 2.0 psig, and in specific embodiments, the pressure level is less than 1.0 psig. In even more specific embodiments, the pressure level is less than 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, O.3., 0.2 or 0.1 psig.
[0035] The pressure level delivered to actuator 115 can be controlled by valve 135. In certain embodiments, valve 135 may be a three-way valve configured to vent excess pressure to atmosphere. Actuator 115 can then exert a force on reservoir 110 so that fluid can be expelled from reservoir 1 10 via conduit 112.
[0036] Fluid control device 150 can be operated to control the amount (e.g. , the total volume, the flow rate, or another fluid flow parameter that is desired to be controlled) of fluid expelled from reservoir 110. As shown in FIG. 1, fluid control device 150 includes a control valve 151 and a metering flow orifice 152. Valve 151 may be configured, for example, as a solenoid valve or pinch valve that can be used to stop the flow of fluid from reservoir 110. In certain exemplary embodiments, when valve 151 is closed to stop fluid flow, valve 135 can be positioned to vent the positive pressure developed by pressure source 130 to atmosphere.
[0037] It is understood that in other embodiments, fluid control device 150 may comprise a different combination of components, including for example, a control valve without an orifice or an orifice without a control valve. In certain embodiments, fluid control device 150 may be controlled via an appropriate control system 155 (e.g., a system comprising software, pressure sensors or other appropriate components). For example, control system 155 may receive an input from a pressure sensor 153 configured to detect a pressure exerted on actuator 115. As shown in FIG. 1, pressure sensor 153 detects pressure in conduit 136, wherein conduit 136 is in fluid communication with actuator 115. Control system 155 may also be configured to provide an output to valve 151 to control the flow of fluid from reservoir 110, based on, for example, the pressure exerted on actuator 115 and the force, or pressure, exerted by the actuator 115 on reservoir 110 and the fluid therein.
[0038] Fluid control device 150 can be operated so that a known, or predetermined, volume and/or flow rate of fluid is expelled from reservoir 110 based on the known pressure level exerted on reservoir 110 and the valve position and/or orifice size of control device 150. In particular embodiments, the rate of fluid flow from reservoir 110 may be controlled at 100 ml/minute. In other embodiments, the flow rate may be controlled at 90, 80, 70, 60, 50, 40, 30, 20 or 10 ml/min.
[0039] By utilizing a positive pressure to expel fluid from reservoir 110 and fluid control device 150 to control the fluid flow from reservoir 110, a user can precisely monitor and administer a desired amount of fluid to wound dressing 120. For example, metering flow orifice 152 can be sized to provide a particular flow rate at a known pressure provided to reservoir 110. The flow rate can be maintained at a substantially constant level because actuator 115 can expand as the volume in reservoir 110 is reduced. With a known flow rate, valve 151 can be operated for a specific length of time to provide a desired fluid volume to wound dressing 120, i.e., the predetermined or desired volume of fluid from reservoir 110 may correspond to the fluid flow rate from reservoir 110 for an elapsed time period. This can reduce the likelihood that excess fluid will be delivered to wound dressing 120 and cause leakage.
[0040] The embodiment shown in FIG. 1 is merely one exemplary embodiment. Other exemplary embodiments may comprise a different configuration or arrangement of components. For example, referring now to FIG. 2, an exemplary embodiment of a system 200 is shown that is similar to that of FIG. 1, but includes an actuator 215 that is configured as an expandable bladder. The components of system 200 sharing the same element numbering as the components discussed in connection with system 100 are equivalent, and thus, will not be further described herein.
[0041] During operation of system 200, actuator 215 expands as the pressure provided from pressure source 130 is increased. In this embodiment, actuator 215 is contained within a reservoir 210, such as a housing. As actuator 215 expands, actuator 215 displaces fluid in reservoir 210 to expel fluid from reservoir 210 in a similar manner as described above in connection with system 100 to provide controlled fluid flow from reservoir 210 to wound dressing 120.
[0042] Referring now to FIG. 3, a flow chart is provided to illustrate an embodiment of a method that may be utilized to operate systems 100 and 200. The flow chart is generally set forth as a logical flow chart diagram. As such, the depicted order and labeled steps are indicative of one non-limiting embodiment of the presented method. Other steps, methods, and the order of execution thereof may be conceived that fall within the scope of this specification.
[0043] In the embodiment shown in FIG. 3, a method 300 is disclosed comprising a series of steps that may be executed for the operation of an exemplary system according to this disclosure. Certain embodiments may comprise a tangible computer readable medium comprising computer readable code that, when executed by a computer, causes the computer to perform operations comprising the steps disclosed in FIG. 3.
[0044] In this exemplary embodiment, step 310 comprises operating a pressure source to exert a positive pressure on a fluid reservoir and to exert a negative pressure on a wound dressing of a negative wound pressure therapy system. Step 320 comprises monitoring a reservoir or fluid pressure and opening a valve to allow fluid to flow from the fluid reservoir to the wound dressing. Step 330 comprises closing the valve to restrict fluid flow from the fluid reservoir to the wound dressing. Step 340 comprises maintaining negative pressure from the pressure source to the wound dressing. The method may additionally include the steps of providing the previously described fluid control device 150, opening control valve 151 associated with fluid control device 150, and subsequently closing control valve 151 after an elapsed time period sufficient to deliver a predetermined volume of fluid from reservoir 110, 210.
[0045] While the apparatus and methods herein have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied without departing from the scope of this specification as defined by the appended claims.

Claims

CLAIMS We claim:
1. A system for delivering fluid to a wound therapy dressing, the system comprising: an actuator configured to engage a fluid reservoir, the actuator adapted to expel fluid from the fluid reservoir, wherein the fluid reservoir is adapted to be in fluid communication with the wound therapy dressing; a pressure source configured to provide positive pressure to the actuator and negative pressure to the wound therapy dressing; and a fluid control device adapted to control fluid communication between the fluid reservoir and the wound therapy dressing.
2. The system of claim 1, wherein the actuator is a compression sleeve positioned circumferentially about the fluid reservoir, the compression sleeve adapted to compress the fluid reservoir and to expel fluid from the fluid reservoir upon application of the positive pressure.
3. The system of claim 1, wherein the actuator is an expandable bladder positioned within the fluid reservoir, the expandable bladder adapted to expand upon application of the positive pressure to displace the fluid in the fluid reservoir and to expel the fluid from the fluid reservoir.
4. The system of claim 1, wherein the fluid control device comprises a control valve and a metering flow orifice, wherein the control valve and the metering flow orifice cooperate to provide a volume of the fluid from the fluid reservoir according to the positive pressure provided to the actuator and a size of the metering flow orifice.
5. The system of claim 4, wherein the control valve is selected from the group consisting of: a solenoid valve and a solenoid- actuated pinch valve.
6. The system of claim 1, wherein the fluid control device comprises a control valve selected from the group consisting of: a solenoid valve and a solenoid-actuated pinch valve.
7. The system of claim 1, wherein the fluid control device comprises a metering flow orifice.
8. The system of claim 1, further comprising a control system configured to control the fluid control device to provide a volume of the fluid from the fluid reservoir according to the positive pressure provided to the actuator.
9. The system of claim 1, wherein the pressure source comprises a vacuum diaphragm pump, the vacuum diaphragm pump having a vacuum port and a positive pressure port, the vacuum port adapted to provide the negative pressure to the wound therapy dressing and the positive pressure port adapted to provide the positive pressure to the actuator.
10. The system of claim 1, further comprising a valve in fluid communication between the actuator and the pressure source, wherein the positive pressure is provided to the actuator through the valve, and wherein the valve is configured to vent excess pressure from the pressure source to atmosphere.
11. The system of claim 1, wherein the pressure source is configured to provide a pressure of between approximately 0.1 psig and approximately 1.0 psig.
12. A system for delivering fluid to a wound therapy dressing, the system comprising: a pump comprising a vacuum port and a positive pressure port, the vacuum port adapted to be in fluid communication with the wound therapy dressing; an expandable member in fluid communication with the positive pressure port, wherein the expandable member is configured to exert a force on fluid within a fluid reservoir to expel fluid from the fluid reservoir, the fluid reservoir adapted to be in fluid communication with the wound therapy dressing; and a valve in fluid communication with the positive pressure port and the expandable member, wherein positive pressure from the positive pressure port is provided to the expandable member through the valve, and wherein the valve is configured to vent pressure to atmosphere.
13. The system of claim 12, further comprising a fluid control device, the fluid control device comprising a metering flow orifice adapted to provide a volume of the fluid from the fluid reservoir according to the positive pressure provided to the expandable member.
14. The system of claim 12, further comprising a fluid control device and a control system, the control system configured to control the fluid control device to provide a volume of the fluid from the fluid reservoir according to the positive pressure provided to the expandable member.
15. The system of claim 14, wherein the fluid control device comprises a control valve selected from the group consisting of a solenoid valve and a solenoid-actuated pinch valve .
16. The system of claim 12, further comprising a fluid control device, the fluid control device comprising a control valve and a metering flow orifice, wherein the control valve and the metering flow orifice cooperate to provide a volume of the fluid from the fluid reservoir according to the positive pressure provided to the expandable member and a size of the metering orifice.
17. The system of claim 12, wherein the positive pressure port is configured to provide a pressure of between approximately 0.1 psig and approximately 1.0 psig to the expandable member.
18. A method of delivering fluid to a wound therapy dressing, the method comprising:
operating a pressure source adapted to exert a positive pressure on fluid in a fluid reservoir and a negative pressure on the wound therapy dressing; monitoring the positive pressure on the fluid; providing a fluid control device adapted to supply the fluid from the fluid reservoir to the wound therapy dressing, the fluid control device comprising a control valve and a metering orifice, the metering orifice being sized to provide a fluid flow rate according to the positive pressure on the fluid; opening the control valve to provide a predetermined volume of the fluid from the fluid reservoir to the wound therapy dressing, the predetermined volume of the fluid corresponding to the fluid flow rate from the fluid reservoir for an elapsed time period; closing the control valve to restrict the fluid flow rate from the fluid reservoir to the wound therapy dressing after the elapsed time period; and maintaining negative pressure from the pressure source to the wound dressing.
19. The method of claim 18, wherein the pressure source is a diaphragm vacuum pump having a vacuum port adapted to provide the negative pressure and a positive pressure port adapted to provide the positive pressure.
20. The method of claim 18, wherein the positive pressure is between approximately 0.1 psig and approximately 1.0 psig.
EP13702512.8A 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing Active EP2802366B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP15179060.7A EP2965768B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing
EP17202174.3A EP3308809B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261585055P 2012-01-10 2012-01-10
PCT/US2013/020360 WO2013106251A1 (en) 2012-01-10 2013-01-04 Systems and methods for delivering fluid to a wound therapy dressing

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP17202174.3A Division EP3308809B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing
EP15179060.7A Division EP2965768B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing

Publications (2)

Publication Number Publication Date
EP2802366A1 true EP2802366A1 (en) 2014-11-19
EP2802366B1 EP2802366B1 (en) 2015-08-19

Family

ID=47633545

Family Applications (3)

Application Number Title Priority Date Filing Date
EP15179060.7A Active EP2965768B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing
EP13702512.8A Active EP2802366B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing
EP17202174.3A Active EP3308809B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP15179060.7A Active EP2965768B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP17202174.3A Active EP3308809B1 (en) 2012-01-10 2013-01-04 Systems for delivering fluid to a wound therapy dressing

Country Status (7)

Country Link
US (3) US9114237B2 (en)
EP (3) EP2965768B1 (en)
JP (2) JP6208147B2 (en)
CN (1) CN104203301B (en)
AU (2) AU2013208271B2 (en)
CA (1) CA2869094C (en)
WO (1) WO2013106251A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
CA2819475C (en) 2010-12-08 2019-02-12 Convatec Technologies Inc. Integrated system for assessing wound exudates
ES2748519T3 (en) 2010-12-08 2020-03-17 Convatec Technologies Inc Wound exudate system accessory
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
CN104684595B (en) 2012-03-12 2017-08-04 史密夫及内修公开有限公司 Decompressor and method
CN105008611A (en) 2012-12-20 2015-10-28 康沃特克科技公司 Processing of chemically modified cellulosic fibres
WO2015126702A1 (en) * 2014-02-20 2015-08-27 Kci Licensing, Inc. Method and system to evacuate one or more dressing using two or more vacuum pumps
KR101637976B1 (en) * 2015-03-10 2016-07-08 (주)시지바이오 Method and apparatus for treating a wound
HUE049136T2 (en) 2015-04-27 2020-08-28 Smith & Nephew Reduced pressure apparatuses
US11123537B2 (en) * 2015-06-29 2021-09-21 Kci Licensing, Inc. Apparatus for irrigation with negative pressure
CA3007003A1 (en) * 2015-12-29 2017-07-06 Kci Licensing, Inc. System and methods for treatment of wounds with negative pressure and peroxy pyruvic acid
US11878106B2 (en) * 2015-12-29 2024-01-23 3M Innovative Properties Company System and methods for the treatment of wounds with negative pressure and instillation of peroxide pyruvic acid
WO2017153357A1 (en) 2016-03-07 2017-09-14 Smith & Nephew Plc Wound treatment apparatuses and methods with negative pressure source integrated into wound dressing
TW201800069A (en) 2016-03-30 2018-01-01 康華特科技有限公司 Detecting microbial infection in wounds
AU2017243601A1 (en) 2016-03-30 2018-11-22 Acib Gmbh Detecting microbial infection in wounds
US11285047B2 (en) 2016-04-26 2022-03-29 Smith & Nephew Plc Wound dressings and methods of use with integrated negative pressure source having a fluid ingress inhibition component
JP6975172B2 (en) 2016-05-03 2021-12-01 スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company Systems and Methods for Driving Negative Pressure Sources in Negative Pressure Therapy Systems
US11096831B2 (en) 2016-05-03 2021-08-24 Smith & Nephew Plc Negative pressure wound therapy device activation and control
CN109069710B (en) 2016-05-03 2022-04-12 史密夫及内修公开有限公司 Optimizing power delivery to a negative pressure source in a negative pressure therapy system
BR112019000301A2 (en) 2016-07-08 2019-04-16 Convatec Technologies Inc. flexible negative pressure system
AU2017292876B2 (en) 2016-07-08 2022-01-20 Convatec Technologies Inc. Fluid collection apparatus
AU2017292028B2 (en) 2016-07-08 2023-03-02 Convatec Technologies Inc. Fluid flow sensing
CA3034789A1 (en) 2016-08-25 2018-03-01 Smith & Nephew Plc Absorbent negative pressure wound therapy dressing
US11564847B2 (en) 2016-09-30 2023-01-31 Smith & Nephew Plc Negative pressure wound treatment apparatuses and methods with integrated electronics
EP3592312B1 (en) 2017-03-08 2024-01-10 Smith & Nephew plc Negative pressure wound therapy device control in presence of fault condition
WO2018163093A1 (en) 2017-03-09 2018-09-13 Secretary, Department Of Biotechnology A wound dressing for combined negative pressure and fluid delivery system
EP3621667A1 (en) 2017-05-09 2020-03-18 Smith & Nephew PLC Redundant controls for negative pressure wound therapy systems
CA3074780A1 (en) 2017-09-13 2019-03-21 Smith & Nephew Plc Negative pressure wound treatment apparatuses and methods with integrated electronics
GB201718070D0 (en) 2017-11-01 2017-12-13 Smith & Nephew Negative pressure wound treatment apparatuses and methods with integrated electronics
GB201718054D0 (en) 2017-11-01 2017-12-13 Smith & Nephew Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods
US11497653B2 (en) 2017-11-01 2022-11-15 Smith & Nephew Plc Negative pressure wound treatment apparatuses and methods with integrated electronics
GB201718072D0 (en) 2017-11-01 2017-12-13 Smith & Nephew Negative pressure wound treatment apparatuses and methods with integrated electronics
US11253401B2 (en) * 2018-08-03 2022-02-22 Kci Licensing, Inc. Wound therapy system with wound volume estimation
USD898925S1 (en) 2018-09-13 2020-10-13 Smith & Nephew Plc Medical dressing
WO2020162953A1 (en) * 2019-02-06 2020-08-13 Kci Licensing, Inc. Wound therapy system with internal alternating orifice
USD907216S1 (en) 2019-02-07 2021-01-05 Kci Licensing, Inc. Therapy device
US11471573B2 (en) * 2019-03-27 2022-10-18 Kci Licensing, Inc. Wound therapy system with wound volume estimation
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
CN115243605A (en) 2020-03-03 2022-10-25 帝皇工业有限公司 Negative pressure wound therapy instillation system
USD945629S1 (en) * 2020-09-08 2022-03-08 Kci Manufacturing Unlimited Company Therapy device
WO2023168353A1 (en) * 2022-03-02 2023-09-07 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same

Family Cites Families (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1355846A (en) 1920-02-06 1920-10-19 David A Rannells Medical appliance
US2547758A (en) 1949-01-05 1951-04-03 Wilmer B Keeling Instrument for treating the male urethra
US2632443A (en) 1949-04-18 1953-03-24 Eleanor P Lesher Surgical dressing
GB692578A (en) 1949-09-13 1953-06-10 Minnesota Mining & Mfg Improvements in or relating to drape sheets for surgical use
US2682873A (en) 1952-07-30 1954-07-06 Johnson & Johnson General purpose protective dressing
NL189176B (en) 1956-07-13 1900-01-01 Hisamitsu Pharmaceutical Co PLASTER BASED ON A SYNTHETIC RUBBER.
US2969057A (en) 1957-11-04 1961-01-24 Brady Co W H Nematodic swab
US3066672A (en) 1960-09-27 1962-12-04 Jr William H Crosby Method and apparatus for serial sampling of intestinal juice
US3367332A (en) 1965-08-27 1968-02-06 Gen Electric Product and process for establishing a sterile area of skin
US3520300A (en) 1967-03-15 1970-07-14 Amp Inc Surgical sponge and suction device
US3568675A (en) 1968-08-30 1971-03-09 Clyde B Harvey Fistula and penetrating wound dressing
US3568676A (en) 1969-01-08 1971-03-09 Victor R Del Guercio Panty-designed diaper cover
US3682180A (en) 1970-06-08 1972-08-08 Coilform Co Inc Drain clip for surgical drain
BE789293Q (en) 1970-12-07 1973-01-15 Parke Davis & Co MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS
US3826254A (en) 1973-02-26 1974-07-30 Verco Ind Needle or catheter retaining appliance
DE2527706A1 (en) 1975-06-21 1976-12-30 Hanfried Dr Med Weigand DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET
DE2640413C3 (en) 1976-09-08 1980-03-27 Richard Wolf Gmbh, 7134 Knittlingen Catheter monitor
NL7710909A (en) 1976-10-08 1978-04-11 Smith & Nephew COMPOSITE STRAPS.
GB1562244A (en) 1976-11-11 1980-03-05 Lock P M Wound dressing materials
US4080970A (en) 1976-11-17 1978-03-28 Miller Thomas J Post-operative combination dressing and internal drain tube with external shield and tube connector
US4139004A (en) 1977-02-17 1979-02-13 Gonzalez Jr Harry Bandage apparatus for treating burns
US4184510A (en) 1977-03-15 1980-01-22 Fibra-Sonics, Inc. Valued device for controlling vacuum in surgery
US4180074A (en) * 1977-03-15 1979-12-25 Fibra-Sonics, Inc. Device and method for applying precise irrigation, aspiration, medication, ultrasonic power and dwell time to biotissue for surgery and treatment
US4187847A (en) * 1977-07-11 1980-02-12 Loeser Edward A Airless intravenous fluid system
US4165748A (en) 1977-11-07 1979-08-28 Johnson Melissa C Catheter tube holder
US4245637A (en) 1978-07-10 1981-01-20 Nichols Robert L Shutoff valve sleeve
SE414994B (en) 1978-11-28 1980-09-01 Landstingens Inkopscentral VENKATETERFORBAND
GB2047543B (en) 1978-12-06 1983-04-20 Svedman Paul Device for treating tissues for example skin
US4266545A (en) 1979-04-06 1981-05-12 Moss James P Portable suction device for collecting fluids from a closed wound
US4284079A (en) 1979-06-28 1981-08-18 Adair Edwin Lloyd Method for applying a male incontinence device
US4261363A (en) 1979-11-09 1981-04-14 C. R. Bard, Inc. Retention clips for body fluid drains
US4569348A (en) 1980-02-22 1986-02-11 Velcro Usa Inc. Catheter tube holder strap
EP0035583B1 (en) 1980-03-11 1985-08-14 Schmid, Eduard, Dr.Dr.med. Skin graft pressure bandage
US4297995A (en) 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4333468A (en) 1980-08-18 1982-06-08 Geist Robert W Mesentery tube holder apparatus
US4465485A (en) 1981-03-06 1984-08-14 Becton, Dickinson And Company Suction canister with unitary shut-off valve and filter features
US4392853A (en) 1981-03-16 1983-07-12 Rudolph Muto Sterile assembly for protecting and fastening an indwelling device
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4392858A (en) 1981-07-16 1983-07-12 Sherwood Medical Company Wound drainage device
FR2510203A1 (en) * 1981-07-24 1983-01-28 Evrard Robert MEMBRANE DRY PRIMARY PUMP
US4419097A (en) 1981-07-31 1983-12-06 Rexar Industries, Inc. Attachment for catheter tube
AU550575B2 (en) 1981-08-07 1986-03-27 Richard Christian Wright Wound drainage device
SE429197B (en) 1981-10-14 1983-08-22 Frese Nielsen SAR TREATMENT DEVICE
DE3146266A1 (en) 1981-11-21 1983-06-01 B. Braun Melsungen Ag, 3508 Melsungen COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE
US4551139A (en) 1982-02-08 1985-11-05 Marion Laboratories, Inc. Method and apparatus for burn wound treatment
US4475909A (en) 1982-05-06 1984-10-09 Eisenberg Melvin I Male urinary device and method for applying the device
US4476909A (en) 1982-06-14 1984-10-16 Levolor Lorentzen, Inc. Cord lock for a venetian blind lift cord
DE3361779D1 (en) 1982-07-06 1986-02-20 Dow Corning Medical-surgical dressing and a process for the production thereof
US4576011A (en) * 1982-11-01 1986-03-18 Electric Power Research Institute Air conditioning system and method of operation
NZ206837A (en) 1983-01-27 1986-08-08 Johnson & Johnson Prod Inc Thin film adhesive dressing:backing material in three sections
US4548202A (en) 1983-06-20 1985-10-22 Ethicon, Inc. Mesh tissue fasteners
US4540412A (en) 1983-07-14 1985-09-10 The Kendall Company Device for moist heat therapy
US4543100A (en) 1983-11-01 1985-09-24 Brodsky Stuart A Catheter and drain tube retainer
US4525374A (en) 1984-02-27 1985-06-25 Manresa, Inc. Treating hydrophobic filters to render them hydrophilic
GB2157958A (en) 1984-05-03 1985-11-06 Ernest Edward Austen Bedding Ball game net support
US4897081A (en) 1984-05-25 1990-01-30 Thermedics Inc. Percutaneous access device
US5215522A (en) 1984-07-23 1993-06-01 Ballard Medical Products Single use medical aspirating device and method
GB8419745D0 (en) 1984-08-02 1984-09-05 Smith & Nephew Ass Wound dressing
US4872450A (en) 1984-08-17 1989-10-10 Austad Eric D Wound dressing and method of forming same
US4826494A (en) 1984-11-09 1989-05-02 Stryker Corporation Vacuum wound drainage system
US4655754A (en) 1984-11-09 1987-04-07 Stryker Corporation Vacuum wound drainage system and lipids baffle therefor
US4605399A (en) 1984-12-04 1986-08-12 Complex, Inc. Transdermal infusion device
US5037397A (en) 1985-05-03 1991-08-06 Medical Distributors, Inc. Universal clamp
US4640688A (en) 1985-08-23 1987-02-03 Mentor Corporation Urine collection catheter
US4710165A (en) 1985-09-16 1987-12-01 Mcneil Charles B Wearable, variable rate suction/collection device
US4758220A (en) 1985-09-26 1988-07-19 Alcon Laboratories, Inc. Surgical cassette proximity sensing and latching apparatus
US4733659A (en) 1986-01-17 1988-03-29 Seton Company Foam bandage
EP0256060A1 (en) 1986-01-31 1988-02-24 OSMOND, Roger L. W. Suction system for wound and gastro-intestinal drainage
US4838883A (en) 1986-03-07 1989-06-13 Nissho Corporation Urine-collecting device
JPS62281965A (en) 1986-05-29 1987-12-07 テルモ株式会社 Catheter and catheter fixing member
GB8621884D0 (en) 1986-09-11 1986-10-15 Bard Ltd Catheter applicator
GB2195255B (en) 1986-09-30 1991-05-01 Vacutec Uk Limited Apparatus for vacuum treatment of an epidermal surface
US4743232A (en) 1986-10-06 1988-05-10 The Clinipad Corporation Package assembly for plastic film bandage
DE3634569A1 (en) 1986-10-10 1988-04-21 Sachse Hans E CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS
JPS63135179A (en) 1986-11-26 1988-06-07 立花 俊郎 Subcataneous drug administration set
GB8628564D0 (en) 1986-11-28 1987-01-07 Smiths Industries Plc Anti-foaming agent suction apparatus
GB8706116D0 (en) 1987-03-14 1987-04-15 Smith & Nephew Ass Adhesive dressings
US4787888A (en) 1987-06-01 1988-11-29 University Of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US4863449A (en) 1987-07-06 1989-09-05 Hollister Incorporated Adhesive-lined elastic condom cathether
WO1989000868A1 (en) * 1987-07-23 1989-02-09 Rosaria Bongiorno Pneumatic device for withdrawing/dispensing fluids
US5176663A (en) 1987-12-02 1993-01-05 Pal Svedman Dressing having pad with compressibility limiting elements
US4906240A (en) 1988-02-01 1990-03-06 Matrix Medica, Inc. Adhesive-faced porous absorbent sheet and method of making same
US4985019A (en) 1988-03-11 1991-01-15 Michelson Gary K X-ray marker
GB8812803D0 (en) 1988-05-28 1988-06-29 Smiths Industries Plc Medico-surgical containers
US4919654A (en) 1988-08-03 1990-04-24 Kalt Medical Corporation IV clamp with membrane
US5000741A (en) 1988-08-22 1991-03-19 Kalt Medical Corporation Transparent tracheostomy tube dressing
JPH02270874A (en) 1989-01-16 1990-11-05 Roussel Uclaf Azabicyclo compounds and their salts, their production, pharmaceutical compound containing them and their use as remedy
GB8906100D0 (en) 1989-03-16 1989-04-26 Smith & Nephew Laminates
US4969880A (en) 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5527293A (en) 1989-04-03 1996-06-18 Kinetic Concepts, Inc. Fastening system and method
US5100396A (en) 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5261893A (en) 1989-04-03 1993-11-16 Zamierowski David S Fastening system and method
JP2719671B2 (en) 1989-07-11 1998-02-25 日本ゼオン株式会社 Wound dressing
US5358494A (en) 1989-07-11 1994-10-25 Svedman Paul Irrigation dressing
US5232453A (en) 1989-07-14 1993-08-03 E. R. Squibb & Sons, Inc. Catheter holder
GB2235877A (en) 1989-09-18 1991-03-20 Antonio Talluri Closed wound suction apparatus
US5134994A (en) 1990-02-12 1992-08-04 Say Sam L Field aspirator in a soft pack with externally mounted container
US5092858A (en) 1990-03-20 1992-03-03 Becton, Dickinson And Company Liquid gelling agent distributor device
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5278100A (en) 1991-11-08 1994-01-11 Micron Technology, Inc. Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5279550A (en) 1991-12-19 1994-01-18 Gish Biomedical, Inc. Orthopedic autotransfusion system
US5167613A (en) 1992-03-23 1992-12-01 The Kendall Company Composite vented wound dressing
FR2690617B1 (en) 1992-04-29 1994-06-24 Cbh Textile TRANSPARENT ADHESIVE DRESSING.
DE4306478A1 (en) 1993-03-02 1994-09-08 Wolfgang Dr Wagner Drainage device, in particular pleural drainage device, and drainage method
US5342376A (en) 1993-05-03 1994-08-30 Dermagraphics, Inc. Inserting device for a barbed tissue connector
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US5344415A (en) 1993-06-15 1994-09-06 Deroyal Industries, Inc. Sterile system for dressing vascular access site
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
US5607388A (en) 1994-06-16 1997-03-04 Hercules Incorporated Multi-purpose wound dressing
US5556375A (en) 1994-06-16 1996-09-17 Hercules Incorporated Wound dressing having a fenestrated base layer
US5664270A (en) 1994-07-19 1997-09-09 Kinetic Concepts, Inc. Patient interface system
DK0853950T3 (en) 1994-08-22 2002-11-25 Kinetic Concepts Inc Wound drainage canisters
US5792109A (en) * 1994-09-01 1998-08-11 Leland L. Ladd Irrigation pump and system
US5810202A (en) * 1994-10-20 1998-09-22 Rick R. Wascher, P.C. Disposable self-dispensing pressurized package for delivery of sterile fluids and solutions
DE29504378U1 (en) 1995-03-15 1995-09-14 Mtg Medizinisch Tech Geraeteba Electronically controlled low-vacuum pump for chest and wound drainage
US5776105A (en) * 1995-09-28 1998-07-07 Children's Medical Center Corp. Ambulatory intravenous fluid holder
GB9523253D0 (en) 1995-11-14 1996-01-17 Mediscus Prod Ltd Portable wound treatment apparatus
JPH09262289A (en) * 1996-03-28 1997-10-07 Terumo Corp Infusion device for liquid medicine
US6635035B1 (en) 2000-05-02 2003-10-21 Patrick V. Marasco Tissue irrigation arrangement
DE19722075C1 (en) * 1997-05-27 1998-10-01 Wilhelm Dr Med Fleischmann Medication supply to open wounds
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
AU755496B2 (en) 1997-09-12 2002-12-12 Kci Licensing, Inc. Surgical drape and suction head for wound treatment
GB9719520D0 (en) 1997-09-12 1997-11-19 Kci Medical Ltd Surgical drape and suction heads for wound treatment
IT1297121B1 (en) * 1997-12-16 1999-08-03 Sviluppo Materiali Spa SURGICAL DEVICE FOR IRRIGATION AND ASPIRATION OF A PHYSIOLOGICAL SOLUTION
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
JP2000024119A (en) * 1998-07-16 2000-01-25 Sumiya Arthroscope liquid feeder
US6458109B1 (en) * 1998-08-07 2002-10-01 Hill-Rom Services, Inc. Wound treatment apparatus
US6488643B1 (en) 1998-10-08 2002-12-03 Kci Licensing, Inc. Wound healing foot wrap
US6083195A (en) * 1998-10-15 2000-07-04 Bausch & Lomb Surgical, Inc. Ophthalmic aspiration system with selectable vent method
US6287316B1 (en) 1999-03-26 2001-09-11 Ethicon, Inc. Knitted surgical mesh
US6856821B2 (en) 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US7799004B2 (en) 2001-03-05 2010-09-21 Kci Licensing, Inc. Negative pressure wound treatment apparatus and infection identification system and method
US6179808B1 (en) * 1999-06-18 2001-01-30 Alcon Laboratories, Inc. Method of controlling the operating parameters of a surgical system
US6991643B2 (en) 2000-12-20 2006-01-31 Usgi Medical Inc. Multi-barbed device for retaining tissue in apposition and methods of use
US6398760B1 (en) 1999-10-01 2002-06-04 Baxter International, Inc. Volumetric infusion pump with servo valve control
US6413238B1 (en) * 1999-09-17 2002-07-02 Baxter International Inc Fluid dispenser with stabilized fluid flow
JP4129536B2 (en) 2000-02-24 2008-08-06 ヴェネテック インターナショナル,インコーポレイテッド Highly compatible catheter anchoring system
JP2002065806A (en) * 2000-08-25 2002-03-05 Nagashima Ika Kikai Kk Medical washing and suction device
US6540705B2 (en) 2001-02-22 2003-04-01 Core Products International, Inc. Ankle brace providing upper and lower ankle adjustment
EP2650027B1 (en) 2002-05-31 2017-09-20 KCI Medical Resources Wound treatment apparatus
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7625362B2 (en) * 2003-09-16 2009-12-01 Boehringer Technologies, L.P. Apparatus and method for suction-assisted wound healing
GB0224986D0 (en) * 2002-10-28 2002-12-04 Smith & Nephew Apparatus
GB0325126D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus with heat
GB0325120D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus with actives
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US8529548B2 (en) 2004-04-27 2013-09-10 Smith & Nephew Plc Wound treatment apparatus and method
GB0409444D0 (en) * 2004-04-28 2004-06-02 Smith & Nephew Apparatus
GB0508529D0 (en) * 2005-04-27 2005-06-01 Smith & Nephew Sai with microstress
GB0424046D0 (en) 2004-10-29 2004-12-01 Smith & Nephew Apparatus
US20060264829A1 (en) 2005-05-10 2006-11-23 Par Technologies, Llc Disposable fluid container with integrated pump motive assembly
WO2006131609A1 (en) * 2005-06-09 2006-12-14 Mireille Guignard Device for irrigating and pressurizing a cavity
US7438705B2 (en) * 2005-07-14 2008-10-21 Boehringer Technologies, L.P. System for treating a wound with suction and method detecting loss of suction
CN101378794A (en) * 2006-02-02 2009-03-04 科洛普拉斯特公司 A suction method and a wound suction system
US8465467B2 (en) * 2006-09-14 2013-06-18 Novartis Ag Method of controlling an irrigation/aspiration system
US20080243096A1 (en) * 2006-10-05 2008-10-02 Paul Svedman Device For Active Treatment and Regeneration of Tissues Such as Wounds
US8257337B2 (en) 2007-05-02 2012-09-04 Carefusion 303, Inc. Intravenous fluid container
EP2047876B1 (en) 2007-10-12 2012-08-29 Dentsply IH AB Self-contained portable apparatus for administration of a drug solution
CA2711620A1 (en) * 2008-01-08 2009-07-16 Bluesky Medical Group Inc. Sustained variable negative pressure wound treatment and method of controlling same
US8021347B2 (en) 2008-07-21 2011-09-20 Tyco Healthcare Group Lp Thin film wound dressing
US9199012B2 (en) * 2008-03-13 2015-12-01 Smith & Nephew, Inc. Shear resistant wound dressing for use in vacuum wound therapy
US8007481B2 (en) 2008-07-17 2011-08-30 Tyco Healthcare Group Lp Subatmospheric pressure mechanism for wound therapy system
US8251979B2 (en) 2009-05-11 2012-08-28 Tyco Healthcare Group Lp Orientation independent canister for a negative pressure wound therapy device
US8216198B2 (en) 2009-01-09 2012-07-10 Tyco Healthcare Group Lp Canister for receiving wound exudate in a negative pressure therapy system
EP2442852B1 (en) * 2009-06-19 2013-05-01 Sanofi-Aventis Deutschland GmbH Injection arrangement for a flowable drug
EP3181162A3 (en) * 2010-01-22 2017-09-27 KCI Licensing, Inc. Devices, systems, and methods for instillation of foamed fluid with negative pressure wound therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2013106251A1 *

Also Published As

Publication number Publication date
US20180154126A1 (en) 2018-06-07
JP2015505266A (en) 2015-02-19
EP2965768A1 (en) 2016-01-13
AU2013208271B2 (en) 2017-04-13
EP2802366B1 (en) 2015-08-19
US20150320917A1 (en) 2015-11-12
JP2018023793A (en) 2018-02-15
US20130211348A1 (en) 2013-08-15
EP3308809B1 (en) 2019-08-21
CA2869094C (en) 2020-06-02
AU2013208271A1 (en) 2014-05-22
JP6490767B2 (en) 2019-03-27
CA2869094A1 (en) 2013-07-18
CN104203301A (en) 2014-12-10
CN104203301B (en) 2017-12-15
US10792482B2 (en) 2020-10-06
EP2965768B1 (en) 2017-11-29
US9907939B2 (en) 2018-03-06
AU2017203229B2 (en) 2017-11-30
AU2017203229A1 (en) 2017-06-08
EP3308809A1 (en) 2018-04-18
WO2013106251A1 (en) 2013-07-18
JP6208147B2 (en) 2017-10-04
US9114237B2 (en) 2015-08-25

Similar Documents

Publication Publication Date Title
US10792482B2 (en) Systems and methods for delivering fluid to a wound therapy dressing
AU2017254890B9 (en) Systems and methods for delivering fluid to a wound therapy dressing
US20210196871A1 (en) Systems and methods for delivering fluid to a wound therapy dressing

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140804

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602013002744

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61M0001000000

Ipc: A61M0035000000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 1/00 20060101ALI20141222BHEP

Ipc: A61M 35/00 20060101AFI20141222BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150205

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KCI LICENSING, INC.

INTG Intention to grant announced

Effective date: 20150306

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150424

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 743358

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150915

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013002744

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151120

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151119

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151221

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20151219

REG Reference to a national code

Ref country code: AT

Ref legal event code: UEP

Ref document number: 743358

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

REG Reference to a national code

Ref country code: DE

Ref legal event code: R026

Ref document number: 602013002744

Country of ref document: DE

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160131

26 Opposition filed

Opponent name: SMITH & NEPHEW, INC.

Effective date: 20160518

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160104

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: KCI LICENSING, INC.

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: KCI LICENSING, INC.

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: SMITH & NEPHEW, INC.

Effective date: 20160518

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: KCI LICENSING, INC.

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

REG Reference to a national code

Ref country code: DE

Ref legal event code: R100

Ref document number: 602013002744

Country of ref document: DE

PLCK Communication despatched that opposition was rejected

Free format text: ORIGINAL CODE: EPIDOSNREJ1

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

PLBN Opposition rejected

Free format text: ORIGINAL CODE: 0009273

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: OPPOSITION REJECTED

27O Opposition rejected

Effective date: 20171013

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20130104

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160131

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602013002744

Country of ref document: DE

Representative=s name: SIMMONS & SIMMONS LLP, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150819

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20200102

Year of fee payment: 8

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: RIEDERER HASLER AND PARTNER PATENTANWAELTE AG, LI

Ref country code: CH

Ref legal event code: PUE

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Free format text: FORMER OWNER: KCI LICENSING, INC., US

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20201203 AND 20201209

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602013002744

Country of ref document: DE

Owner name: SOLVENTUM INTELLECTUAL PROPERTIES CO. (N.D.GES, US

Free format text: FORMER OWNER: KCI LICENSING, INC., SAN ANTONIO, TEX., US

Ref country code: DE

Ref legal event code: R082

Ref document number: 602013002744

Country of ref document: DE

Representative=s name: SIMMONS & SIMMONS LLP, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 602013002744

Country of ref document: DE

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, ST. PAUL, US

Free format text: FORMER OWNER: KCI LICENSING, INC., SAN ANTONIO, TEX., US

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20201217

Year of fee payment: 9

Ref country code: IE

Payment date: 20201221

Year of fee payment: 9

REG Reference to a national code

Ref country code: AT

Ref legal event code: PC

Ref document number: 743358

Country of ref document: AT

Kind code of ref document: T

Owner name: 3M INNOVATIVE PROPERTIES COMPANY, US

Effective date: 20210118

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20201221

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20201221

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210104

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20220201

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 743358

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220201

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220104

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230102

Year of fee payment: 11

Ref country code: DE

Payment date: 20221220

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231219

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231219

Year of fee payment: 12

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20240208 AND 20240214

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602013002744

Country of ref document: DE

Owner name: SOLVENTUM INTELLECTUAL PROPERTIES CO. (N.D.GES, US

Free format text: FORMER OWNER: 3M INNOVATIVE PROPERTIES COMPANY, ST. PAUL, MN, US